ELI LILLY, 1998 (A): STRATEGIC CHALLENGES HARVARD CASE STUDY 399173.

SUBJECT INDEX:

1.	ANTHROPOLOGY
2.	ARCHITECTURE
3.	ART
4.	BLACK STUDIES
5.	BUSINESS
6.	CRIMINOLOGY AND LAW
7.	ECONOMY
8.	EDUCATION
10.	HISTORY
11.	JOURNALISM
12.	LABOR
13.	LINGUISTICS
14.	LITERATURE
15.	MEDIA
16.	MEDICINE AND HEALTH CARE
17.	MUSIC
18.	PHILOSOPHY
19.	POLITICAL SCIENCE
20.	PSYCHOLOGY
21.	RELIGION
22.	SOCIOLOGY
23.	SCIENCE
24.	WOMEN STUDIES
25.	AREA STUDIES

30,000 Term Papers
To Choose From..

Find Academic, Research, College, and University Term Papers

Search Our Catalog For A Term Paper, Book Report, Case Study or Essay.

We Provide Custom Research, Term Paper Writing, Pre-written Reports and Editing...

"$name" TERM PAPERS

Academic Term Papers Catalog

ELI LILLY, 1998 (A): STRATEGIC CHALLENGES HARVARD CASE STUDY 399173.

17462. ELI LILLY, 1998 (A): STRATEGIC CHALLENGES HARVARD CASE STUDY 399173. This paper provides a 14-point action research model case analysis and case solution to a Harvard Business School case study (399173) by Michael Y. Yoshino and Thomas W. Malnight which focuses on pharmaceutical giant Eli Lilly’s strategic challenges in 1998. Although Lilly has grown over the previous decade and although it has a strong leadership position in the neurosciences with its Prozac and Zyprexa products, the company faces numerous market challenges related to changing demographics, intensifying competition, industry consolidation, regulatory pressures and healthcare industry cost constraints. It is recommended that Lilly diversify its product portfolio, cautiously begin acquiring small firms, and work to change its organizational culture to encourage flexibility and organization-wide learning. KEYWORDS: case study case studies pharmaceutical industry Eli Lilly and Company strategy strategic management strategic international marketing action research consolidation research and development teams globalization case solution. APA Style. 14 pages, 9 footnotes, 7 bibliographic sources. 3,440 words.

$98